Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

biopharma

This page shows the latest biopharma news and features for those working in and with pharma, biotech and healthcare.

AZ’s Sean Bohen to exit after business overhaul; report

AZ’s Sean Bohen to exit after business overhaul; report

Immunocore, and Ludovic Helfgott – AZ’s head of cardiovascular and metabolic diseases – is set to join Novo Nordisk as executive vice president of its biopharma unit.

Latest news

  • Pfizer takeover rumour ignites Amarin shares Pfizer takeover rumour ignites Amarin shares

    Fish oil product shows great promise. Pfizer is rumoured to be on the brink of a deal to acquire small biopharma Amarin in the wake of stellar data for its purified

  • BMS and Celgene announce $74bn merger BMS and Celgene announce $74bn merger

    The biopharma mega-merger is back: Bristol-Myers Squibb is to pay $74bn to acquire Celgene in a deal which will shake up the sector and create a new leader in ... BMS CEO Giovanni Caforio. “Together with Celgene, we are creating an innovative biopharma

  • Pharma’s R&D productivity sinks to a new low Pharma’s R&D productivity sinks to a new low

    In addition to the 12 original cohort companies, since 2015 four smaller and more specialised biopharma companies have been used as an extension cohort of the R&D study, although Deloitte

  • Axovant drops last ‘legacy’ drug to focus on gene therapies Axovant drops last ‘legacy’ drug to focus on gene therapies

    That was followed swiftly by a $10m upfront deal with Benitec Biopharma for rights to a preclinical stage gene therapy for rare disease oculopharyngeal muscular dystrophy (OPMD), due to start trials

  • eConsent: Busting regulatory myths eConsent: Busting regulatory myths

    One of these is TransCelerate Biopharma’s eConsent initiative, which seeks to facilitate broad adoption of this technology and has provided a framework for eConsent digital components, as well as a

More from news
Approximately 9 fully matching, plus 359 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    Strongbridge. Biopharma/ Novo. Nordisk. MACRILEN (macimorelin) for diagnosis of adult growth.

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Onpattro’s competition. As is so typical of today’s biopharma sector, even when companies bring highly innovative medicines to market, there is very often a competitor or.

  • Redefining communications excellence Redefining communications excellence

    While biopharma companies can rely on third parties for lots of the communication creation process, their own staff typically play a central role in discussions about who the key stakeholders are

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene aims to be the first home-grown big biopharma. " />. BeiGene aims to be the first home-grown big biopharma. " />. BeiGene aims to be the first home-grown big biopharma. BeiGene ... is one of a new wave of Chinese biopharma companies to list on

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    The rise of Chinese biopharma. One home-grown pharma company which could replicate this accomplishment is Beijing-headquartered BeiGene. ... BeiGene’s CEO John Oyler told a Goldman Sachs recent conference that a Chinese biopharma sector was ready to

More from intelligence
Approximately 1 fully matching, plus 66 partially matching documents found.

Latest appointments

More from appointments
Approximately 8 fully matching, plus 136 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Quick links

Infographics

Multimedia